SCHEMBL7247258

SCHEMBL7247258

COc1ccc(NC(N)=S)cc1CNC(=O)OC(C)(C)C

nearest known ligand 0.56

Predicted protein targets (top 19)

geneUniProtsupporting neighboursconfidence
ALDH1A1 P00352 3/20 0.56
GAA P10253 1/20 0.56
LMNA P02545 1/20 0.44
KMT2A Q03164 1/20 0.43
IMPDH2 P12268 1/20 0.41
IMPDH1 P20839 1/20 0.41
PKM P14618 1/20 0.41
CYP1A2 P05177 1/20 0.40
CYP2C9 P11712 1/20 0.40
CYP2C19 P33261 1/20 0.40
KDM4E B2RXH2 1/20 0.40
SMN1; SMN2 Q16637 1/20 0.40
CFTR P13569 1/20 0.40
QPCT Q16769 1/20 0.39
P2RX5 Q93086 1/20 0.39
P2RX4 Q99571 1/20 0.39
P2RX7 Q99572 1/20 0.39
P2RX2 Q9UBL9 1/20 0.39
MAPKAPK2 P49137 1/20 0.39

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL6679066 0.89 ALDH1A1 (0.54) ALDH1A1GAAKMT2ACFTR
SCHEMBL6677097 0.89 ALDH1A1 (0.46) ALDH1A1GAAMAPKAPK2
SCHEMBL6680600 0.86 ALDH1A1 (0.48) ALDH1A1GAALMNAKMT2AIMPDH2
SCHEMBL6675952 0.84 CYP2C9 (0.45) ALDH1A1GAALMNACYP2C9P2RX4
SCHEMBL6679970 0.83 ALDH1A1 (0.45) ALDH1A1GAALMNAKMT2AIMPDH2
SCHEMBL6680596 0.83 ALDH1A1 (0.46) ALDH1A1GAALMNAKMT2AIMPDH2
SCHEMBL7246442 0.82 ALDH1A1 (0.44) ALDH1A1GAALMNAKMT2AIMPDH2
SCHEMBL7244826 0.82 ALDH1A1 (0.54) ALDH1A1GAAKMT2AIMPDH2IMPDH1
SCHEMBL27389055 0.81 GAA (0.44) ALDH1A1GAALMNAKMT2AKDM4E
SCHEMBL6675050 0.81 ALDH1A1 (0.45) ALDH1A1GAALMNAKMT2AIMPDH2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-6534546-B1 Guanidine- or isothioureido-N-derived anilines; brain, nervous system, and neurodegenerative disorders CHUGAI SEIYAKU KABUSHIKI KAISHA (JP) 2003-03-18 US disclosed
EP-0798292-A1 ANILINE DERIVATIVES HAVING NITROGEN MONOXIDE SYNTHASE INHIBITORY ACTIVITY Chugai Seiyaku Kabushiki Kaisha (JP) 1997-10-01 EP disclosed